Detalhe da pesquisa
1.
A landscape of driver mutations in melanoma.
Cell
; 150(2): 251-63, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22817889
2.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858723
3.
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.
Proc Natl Acad Sci U S A
; 116(52): 26823-26834, 2019 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826955
4.
cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries.
BMC Bioinformatics
; 22(1): 611, 2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34952565
5.
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.
Breast Cancer Res Treat
; 189(2): 411-423, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302589
6.
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
J Natl Compr Canc Netw
; : 1-8, 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761455
7.
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
Br J Cancer
; 119(6): 707-712, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220708
8.
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors.
Oncologist
; 23(4): 401-e38, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593099
9.
Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.
Genet Med
; 20(8): 855-866, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29144510
10.
Melanoma genome sequencing reveals frequent PREX2 mutations.
Nature
; 485(7399): 502-6, 2012 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622578
11.
Response and acquired resistance to everolimus in anaplastic thyroid cancer.
N Engl J Med
; 371(15): 1426-33, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25295501
12.
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Genet Med
; 19(7): 787-795, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28125075
13.
Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies.
Clin Chem
; 63(10): 1605-1613, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679646
14.
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
Proc Natl Acad Sci U S A
; 111(51): E5564-73, 2014 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512523
15.
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Genet Med
; 18(10): 1011-9, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26866579
16.
Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
Invest New Drugs
; 33(5): 1108-14, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26123926
17.
Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Curr Oncol Rep
; 17(4): 15, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708799
18.
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.
Mol Cancer
; 13: 141, 2014 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894453
19.
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.
Invest New Drugs
; 32(1): 178-87, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24242861
20.
CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast Cancer.
NEJM Evid
; 3(5): EVIDoa2300231, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815172